No definition available.
Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
C3_THYROID_PAPILLARY_ADENO_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
2494 |
4. Check minimum number of eventsNone |
2494 |
5. Include endpointsNone |
2494 |
6. Filter based on genotype QC (FinnGen only) |
2494 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2494 | 1890 | 604 |
| Unadjusted period prevalence (%) | 0.55 | 0.64 | 0.27 |
| Median age at first event (years) | 51.24 | 49.15 | 57.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1815
- Matched controls
- 18151
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03AA01
ATC
levothyroxine sodium; systemic
125.8
323.0
1748
3116
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
323.0
1815
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
323.0
1597
*
BAA60
NOMESCO Finland
Total thyroidectomy
196.8
323.0
1094
139
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
102.7
323.0
420
53
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
91.5
323.0
528
81
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
323.0
487
*
104
Kela drug reimbursment
Thyroid insufficiency
83.8
323.0
1417
738
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
211.7
323.0
527
35
EP1AE
NOMESCO Finland
Neck ultrasound examination
56.0
323.0
913
322
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
305.0
284
*
ZX114
NOMESCO Finland
Intramuscular
65.6
296.4
342
64
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
285.1
266
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.1
274.7
1103
3664
4CJ01
NOMESCO Finland
NA
+∞
260.9
244
*
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
2565.7
249.7
236
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
26.1
224.3
319
147
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
221.5
208
*
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
211.7
199
*
130
Kela drug reimbursment
Malignant tumour
+∞
203.0
191
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
38.6
196.2
251
75
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
174.9
165
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
29.4
156.4
214
82
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
154.4
146
*
115
Kela drug reimbursment
Breast cancer
+∞
141.5
134
*
2506
FHL
Thyroidectomy
248.6
136.0
138
6
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
67.2
133.6
154
25
T71
ICPC
Malignant neoplasm thyroid
+∞
133.0
126
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
105.8
126.0
137
14
A11CC03
ATC
alfacalcidol; systemic
19.5
125.7
195
111
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
130.3
124.9
133
11
106
Kela drug reimbursment
Hypoparathyroidism
185.0
116.9
121
7
PJA12
NOMESCO Finland
Sentinel node biopsy
1180.1
114.9
111
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
9.0
113.2
253
319
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
111.9
687
2695
H02AB02
ATC
dexamethasone; systemic
20.0
108.1
166
91
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
107.4
102
*
Z51.88
ICD-10 Finland
Other specified medical care
17.7
102.9
165
102
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
98.6
554
1988
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
989.2
96.9
94
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
91.4
87
*
C739
ICD-10 Finland
NA
+∞
87.2
83
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
94.7
81.8
90
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
79.8
676
3149
A04AA02
ATC
granisetron; systemic, transdermal
112.8
79.6
86
8
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
16.3
75.4
124
81
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
70.3
67
*
A11CC02
ATC
dihydrotachysterol; oral
111.7
69.4
75
7
WX402
NOMESCO Finland
General anaesthesia
3.3
68.1
398
1418
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
45.7
67.6
83
19
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
86.9
67.5
75
9
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
67.1
64
*
HAC20
NOMESCO Finland
Total mastectomy
228.1
64.6
66
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
628.9
62.2
61
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
22.2
62.0
91
43
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
10.8
61.7
122
120
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
60.8
58
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
60.8
58
*
L02BA01
ATC
tamoxifen; oral
112.3
60.2
65
6
JN4BD
NOMESCO Finland
Extensive body CT
6.1
60.1
172
304
A12AA04
ATC
calcium carbonate; oral
16.5
57.7
94
60
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
56.5
54
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
50.4
56.5
68
14
WF002
NOMESCO Finland
Radical radiotherapy
81.6
56.3
63
8
E83.51
ICD-10 Finland
Hypocalcemia
29.3
56.1
76
27
HA1AA
NOMESCO Finland
X-ray mammography
6.8
55.9
148
235
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
8.3
55.5
127
162
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
54.4
52
*
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
20.4
54.4
82
42
WF003
NOMESCO Finland
Adjuvant radiotherapy
532.8
52.8
52
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.3
52.0
144
243
C61
ICD-10 Finland
Malignant neoplasm of prostate
181.8
51.2
53
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
50.2
48
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
50.2
48
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
50.2
48
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
49.2
47
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.5
48.1
130
212
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
62.9
47.5
55
9
XX3DW
NOMESCO Finland
Time consuming IT work
5.0
47.3
162
352
GD1AD
NOMESCO Finland
Thorax CT examination
6.4
47.0
128
211
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
469.3
46.5
46
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.5
46.3
175
421
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
46.0
44
*
A12AA06
ATC
calcium lactate gluconate; oral
120.5
43.9
47
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
427.2
42.3
42
*
JN5SN
NOMESCO Finland
NA
+∞
41.8
40
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
41.3
332
1411
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.3
38.8
63
40
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
38.7
37
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
38.7
37
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
38.7
37
*
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
15.4
38.6
64
43
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
199.1
37.9
39
*
WZC30
NOMESCO Finland
Teaching
2.9
36.7
240
893
JN4AD
NOMESCO Finland
Body CT examination
5.8
36.6
107
193
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
36.6
35
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.4
36.1
88
124
L02BG04
ATC
letrozole; oral
8.6
35.8
79
95
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
129.3
35.8
38
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
35.4
197
655
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
30.1
35.2
47
16
WW200
NOMESCO Finland
Immunization
6.4
34.7
94
154
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
64.6
33.1
38
6
ZX070
NOMESCO Finland
Intensity modified radiotherapy
332.9
33.0
33
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
32.4
31
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
32.4
31
*
ZXA10
NOMESCO Finland
Bilateral
2.2
32.0
394
2051
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
31.9
717
4721
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
31.5
113
257
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
31.3
30
*
T86
ICPC
Hypothyroidism/myxoedema
4.0
31.1
132
353
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.1
30.5
123
314
A04AA01
ATC
ondansetron; systemic, rectal
5.6
29.5
89
167
ZX090
NOMESCO Finland
Other technic of radiotherapy
296.5
28.8
29
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
28.2
27
*
116
Kela drug reimbursment
Prostate cancer
+∞
28.2
27
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
28.2
27
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
28.2
27
*
L01BC06
ATC
capecitabine; oral
+∞
28.2
27
*
C50
ICD-10 Finland
Malignant neoplasm of breast
285.7
27.8
28
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
27.1
26
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
27.1
26
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.3
26.9
60
74
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
46.5
26.5
32
7
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
26.1
25
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
26.1
25
*
GD6AD
NOMESCO Finland
CT of chest and neck
73.8
25.8
29
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.8
25.6
112
308
ZXA05
NOMESCO Finland
Left side
1.9
25.4
454
2713
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
25.4
25.3
35
14
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
25.1
24
*
JN6AD
NOMESCO Finland
CT of torso and neck
21.6
24.8
36
17
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
7.4
24.6
59
82
N02BE01
ATC
paracetamol; systemic, rectal
1.9
24.5
1544
13533
XX1MN
NOMESCO Finland
Isotope examination with measurement
+∞
24.0
23
*
A04AD12
ATC
aprepitant; systemic
+∞
24.0
23
*
E8901, C7391
ICD-10 Finland
NA
+∞
24.0
23
*
BA1AQ
NOMESCO Finland
Thyroid SPECT with low dose CT
+∞
24.0
23
*
L03AA02
ATC
filgrastim; parenteral
47.3
23.3
28
6
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
54.7
23.1
27
5
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
23.0
22
*
BAA99
NOMESCO Finland
Other operation on thyroid gland
121.5
22.6
24
*
Z51.5
ICD-10 Finland
Palliative care
6.5
22.1
58
92
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
35.5
22.1
28
8
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
21.9
21
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
21.9
21
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
21.9
21
*
198
Kela drug reimbursment
Sorafenib
+∞
21.9
21
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
8.7
21.9
47
55
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
81.1
21.7
24
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
222.5
21.6
22
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
116.4
21.6
23
*
WX704
NOMESCO Finland
Intubation
2.7
21.5
150
577
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
20.9
20
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
20.9
20
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.0
20.7
39
36
ZX080
NOMESCO Finland
Image guided radiotherapy
111.3
20.6
22
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
48.6
20.2
24
5
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
6.4
19.8
52
83
TQW20
NOMESCO Finland
Tatoe
74.3
19.7
22
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
5.1
19.7
62
124
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
19.2
399
2476
NK6AN
NOMESCO Finland
Total body bone isotope imaging
20.3
19.1
28
14
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
18.8
18
*
X76
ICPC
Malignant neoplasm breast female
191.9
18.6
19
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.2
18.2
34
31
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
17.7
17
*
1930X
ICD-9 Finland
Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]
+∞
17.7
17
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
17.7
17
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
96.0
17.6
19
*
L03AA14
ATC
lipegfilgrastim; parenteral
181.7
17.5
18
*
ZXA00
NOMESCO Finland
Right side
1.7
17.0
451
2995
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.7
16.9
36
42
N02AA05
ATC
oxycodone; systemic
2.2
16.9
180
861
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
63.9
16.8
19
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
63.9
16.8
19
*
R49.01
ICD-10 Finland
Functional dysphonia
3.3
16.7
84
260
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
16.7
16
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
90.9
16.6
18
*
2504
FHL
Unilateral resection or enucleation
8.0
16.6
37
47
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
171.5
16.5
17
*
B01AB05
ATC
enoxaparin; parenteral
1.6
16.5
467
3155
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.6
16.4
33
35
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
16.3
106
391
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.8
15.9
103
379
Z50.5
ICD-10 Finland
Speech therapy
6.7
15.9
40
61
Z31.5
ICD-10 Finland
Genetic counselling
3.0
15.7
95
333
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
15.6
15
*
323
Kela drug reimbursment
Sorafenib
+∞
15.6
15
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
15.6
15
*
L01XE05
ATC
[U] sorafenib; oral
+∞
15.6
15
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
15.6
15
*
1AB01
NOMESCO Finland
NA
+∞
15.6
15
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.2
15.6
37
52
Y77
ICPC
Malignant neoplasm prostate
161.3
15.5
16
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
161.3
15.5
16
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
161.3
15.5
16
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
38.4
15.4
19
5
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
15.0
319
1978
JN4CD
NOMESCO Finland
Very extensive body CT
5.0
14.8
47
96
A79
ICPC
Malignancy NOS
57.1
14.8
17
*
S18
ICPC
Laceration/cut
1.5
14.8
647
4843
XX9XW
NOMESCO Finland
NA
10.5
14.7
28
27
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
14.6
14
*
WA039
NOMESCO Finland
Radiotherapy with free isotopes
+∞
14.6
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
14.6
14
*
L02BG06
ATC
exemestane; oral
+∞
14.6
14
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
6.3
14.6
38
61
PJA10
NOMESCO Finland
Exploration of lymph nodes
10.1
14.5
28
28
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
36.3
14.4
18
5
L02BG03
ATC
anastrozole; oral
36.3
14.4
18
5
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
10.5
14.2
27
26
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.9
14.0
58
154
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
24.0
13.8
19
8
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
13.8
74
242
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
75.7
13.6
15
*
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
75.7
13.6
15
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
14.8
13.6
22
15
R4110
NOMESCO Finland
Physiotherapy
1.6
13.6
399
2701
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
13.6
13
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
13.6
13
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
13.6
13
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
13.6
13
*
BA2MN
NOMESCO Finland
Thyroid radiation dose measurement during isotope therapy
+∞
13.6
13
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
13.6
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
34.3
13.5
17
5
ZX112
NOMESCO Finland
Subcutaneous
7.6
13.2
30
40
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.6
13.0
59
170
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.4
13.0
30
41
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
50.4
12.8
15
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.6
12.8
23
20
ENB50
NOMESCO Finland
Excision of cyst or fistula of thyroglossic duct
70.3
12.6
14
*
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
70.3
12.6
14
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
12.5
12
*
1508
Kela drug reimbursment
Lenvatinib
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.5
12
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
12.5
12
*
3019
Kela drug reimbursment
Lenvatinib
+∞
12.5
12
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
12.5
12
*
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
130.8
12.4
13
*
R13
ICD-10 Finland
Dysphagia
2.3
12.4
114
512
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.5
12.0
42
96
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
21.4
12.0
17
8
XW000
NOMESCO Finland
Bone marrow biopsy
3.5
11.9
54
156
R49.08
ICD-10 Finland
Other specified dysphonia
3.5
11.9
55
162
KCD02
NOMESCO Finland
Transurethral resection of bladder
16.5
11.7
18
11
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
2.9
11.6
72
259
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
65.4
11.6
13
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
11.6
227
1366
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
9.3
11.5
23
25
JN5AN
NOMESCO Finland
Total body isotope imaging
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
11.5
11
*
L01XE29
ATC
[U] lenvatinib; oral
+∞
11.5
11
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
11.5
11
*
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
11.9
11.3
20
17
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
35.2
11.3
14
*
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
35.2
11.3
14
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
11.3
83
333
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.2
11.0
20
18
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
11.0
98
433
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
15.6
10.8
17
11
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.1
10.8
33
66
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
28.2
10.7
14
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
10.7
130
663
R4130
NOMESCO Finland
Speech therapy
3.8
10.6
43
114
SPAT1153
SPAT
Removal of sutures
1.5
10.5
476
3534
C90.0
ICD-10 Finland
Multiple myeloma
110.6
10.4
11
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
10.4
10
*
L02BX02
ATC
degarelix; parenteral
+∞
10.4
10
*
1CD02
NOMESCO Finland
NA
+∞
10.4
10
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.9
10.3
60
208
E03
ICD-10 Finland
Other hypothyroidism
2.0
10.3
123
623
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
18.9
10.3
15
8
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
9.6
10.3
20
21
ZZF00
NOMESCO Finland
Graft of adipose tissue
11.3
10.1
18
16
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
10.0
235
1492
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
9.8
117
589
ZX120
NOMESCO Finland
Intravenous
2.1
9.6
111
555
J01DB01
ATC
cefalexin; oral
1.4
9.5
1387
12599
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
15.1
9.5
15
10
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
7.2
9.5
22
31
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
100.5
9.4
10
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
100.5
9.4
10
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
17.6
9.4
14
8
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.2
9.4
28
55
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
9.4
9
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
9.4
9
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
9.4
9
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
9.4
9
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
9.4
9
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
9.4
9
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
9.4
9
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
21.8
9.3
13
6
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
8.7
9.3
19
22
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
9.3
121
631
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
4.7
9.2
30
65
RL210
NOMESCO Finland
NA
7.3
9.2
21
29
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
9.2
114
585
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.8
9.1
170
1005
E83.50
ICD-10 Finland
Hypercalcemia
4.7
9.0
29
62
H03BB01
ATC
carbimazole; oral
2.3
9.0
83
374
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
18.7
8.9
13
7
4701
FHL
Neck lymph node removal
12.6
8.9
15
12
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
8.7
173
1044
B01AB10
ATC
tinzaparin; parenteral
2.3
8.7
79
356
A06AH03
ATC
naloxegol; oral
14.1
8.7
14
10
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
8.6
106
543
UDQ02
NOMESCO Finland
Direct laryngoscopy
5.8
8.6
23
40
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.9
8.5
33
85
S77
ICPC
Malignant neoplasm of skin
27.6
8.5
11
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
90.4
8.4
9
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
90.4
8.4
9
*
L02BB03
ATC
bicalutamide; oral
90.4
8.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
90.4
8.4
9
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
8.3
8
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
8.3
8
*
2509
FHL
Other measure in this category
+∞
8.3
8
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
8.3
8
*
L01CA04
ATC
vinorelbine; systemic
+∞
8.3
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.3
8
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
8.3
8
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
8.3
8
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
8.3
8
*
GBB00
NOMESCO Finland
Tracheostomy
6.2
8.3
21
34
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.5
8.3
37
108
L02AE02
ATC
leuprorelin; implant, parenteral
4.2
8.3
30
73
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
9.5
8.3
16
17
A02BC05
ATC
esomeprazole; systemic
1.4
8.1
667
5459
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
4.2
8.1
29
70
HAE99
NOMESCO Finland
Other reconstruction of breast
17.2
8.1
12
7
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
17.2
8.1
12
7
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
8.0
108
574
C08CA01
ATC
amlodipine; oral
1.4
8.0
500
3911
WW500
NOMESCO Finland
Blood transfusion
3.1
8.0
42
139
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
1.9
8.0
115
627
R50.9
ICD-10 Finland
Fever, unspecified
1.7
7.9
172
1068
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.9
7.9
24
49
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
7.8
7.9
17
22
T85
ICPC
Hyperthyroidism/thyrotoxicosis
6.1
7.8
20
33
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
4.3
7.8
27
63
DQE20
NOMESCO Finland
Implantation of foreign material in vocal chord
45.2
7.7
9
*
2260A
ICD-9 Finland
Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]
15.1
7.7
12
8
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
7.6
41
138
WX110
NOMESCO Finland
Local anesthesy
1.3
7.6
1122
9984
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
18.4
7.6
11
6
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.2
7.6
27
65
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
25.1
7.6
10
*
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
25.1
7.6
10
*
S04
ICPC
Lump/swelling localized
1.7
7.5
140
828
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
2.1
7.5
80
389
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.6
7.5
31
86
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.9
7.5
43
150
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
80.4
7.4
8
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
80.4
7.4
8
*
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
7.3
77
373
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
7.3
7
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
7.3
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.3
7
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.3
7
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
7.3
7
*
L02BA03
ATC
fulvestrant; parenteral
+∞
7.3
7
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
4.5
7.3
24
54
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.2
629
5173
Q18.8
ICD-10 Finland
Other specified congenital malformations of face and neck
20.1
7.1
10
5
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
6.6
7.1
17
26
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
7.9
7.1
15
19
E21.0
ICD-10 Finland
Primary hyperparathyroidism
3.2
7.1
34
106
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
7.0
31
91
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.0
150
928
N63
ICD-10 Finland
Unspecified lump in breast
1.9
6.9
91
480
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
5.5
6.9
19
35
ZXB10
NOMESCO Finland
Medial
7.6
6.9
15
20
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
6.8
211
1431
UJC01
NOMESCO Finland
Scopy of lower throat
5.0
6.8
20
40
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
9.3
6.8
13
14
R49.09
ICD-10 Finland
Unspecified dysphonia
3.7
6.8
27
73
T73
ICPC
Neoplasm endocrine other/unspecified
40.2
6.8
8
*
BAA30
NOMESCO Finland
Excision of thyroid isthmus
16.7
6.7
10
6
ELB40
NOMESCO Finland
Partial parotidectomy
4.3
6.7
23
54
R07.0
ICD-10 Finland
Pain in throat
1.9
6.7
97
529
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
7.2
6.7
15
21
UGB02
NOMESCO Finland
Tracheoscopy
22.6
6.7
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
6.6
71
344
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
6.6
56
245
XKD00
NOMESCO Finland
Uroflowmetry
1.7
6.5
141
874
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.8
6.5
20
42
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.7
6.5
126
759
EP1AE
SPAT
NA
3.3
6.5
30
92
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
70.1
6.4
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
70.1
6.4
7
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
70.1
6.4
7
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
70.1
6.4
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
14.4
6.4
10
7
A02BC02
ATC
pantoprazole; systemic
1.3
6.4
1030
9167
B01AB04
ATC
dalteparin; parenteral
2.1
6.3
69
337
UDC00
NOMESCO Finland
Ear microscopy
1.8
6.3
103
589
ZZR10
NOMESCO Finland
Flap of skin and muscle
18.1
6.3
9
5
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
18.1
6.3
9
5
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.3
6
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
6.3
6
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
6.3
6
*
C75.0
ICD-10 Finland
Malignant neoplasm: Parathyroid gland
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
L01EX08
ATC
lenvatinib; oral
+∞
6.3
6
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
4707
FHL
Dissection Colli radicalis
+∞
6.3
6
*
C75
ICD-10 Finland
Malignant neoplasm of other endocrine glands and related structures
+∞
6.3
6
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
C73.93
ICD-10 Finland
Anaplastic thyroid carcinoma (thyroid)
+∞
6.3
6
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
GAB20
NOMESCO Finland
Median sternotomy
26.8
6.2
8
*
WX734
NOMESCO Finland
JET-ventilation
26.8
6.2
8
*
ZZR00
NOMESCO Finland
Flap of skin
6.3
6.2
15
24
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
6.1
96
540
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.7
6.1
13
17
H02AB09
ATC
hydrocortisone; systemic
2.8
6.1
36
130
M05BX04
ATC
denosumab; parenteral
2.1
6.1
61
291
KAC10
NOMESCO Finland
Total nephrectomy with capsule
12.6
6.1
10
8
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.6
6.1
10
8
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.9
6.0
84
454
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
10.0
6.0
11
11
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
6.0
199
1373
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
702
1519
6.04
323.01
3.4
3.6
48.2
84.5
ng/l
36.65
634
1307
2007
9400
6.82
307.65
12.3
5.4
1.2
1.2
mmol/l
41.87
1716
7947
574
314
23.45
307.65
1.6
1.3
—
—
—
0
0
1535
1388
27.18
307.65
7.3
3.0
4.5
4.5
pmol/l
0.20
1491
1220
1814
104
637.74
307.65
7.9
1.1
57.9
153.7
u/ml
0.75
681
30
1846
8457
5.56
307.65
10.3
5.0
1.2
1.2
mmol/l
31.08
1775
7509
1352
6207
3.57
213.37
4.1
2.0
2.3
2.4
mmol/l
37.10
1234
5244
2387
17183
10.15
174.53
11.6
4.2
17.8
14.7
pmol/l
307.65
2330
15800
1490
8937
2.66
120.73
2.9
2.3
78.8
78.3
nmol/l
0.30
1412
8014
638
2611
2.94
108.83
3.6
2.6
0.8
0.8
mmol/l
1.50
608
2399
1417
8627
2.49
106.05
4.1
3.6
—
—
—
0
0
1272
7838
2.27
86.28
5.3
3.8
36.5
36.2
g/l
1.34
1203
7190
705
3370
2.52
85.90
3.7
2.1
2.4
2.4
mmol/l
13.49
636
2876
2401
20039
6.37
85.14
15.3
5.0
1.6
2.0
mu/l
1.83
2318
18534
1993
15238
2.54
75.84
9.5
5.5
75.1
74.5
u/l
0.35
1928
14120
785
4240
2.24
70.09
2.2
2.0
—
—
—
0
0
376
1448
2.88
69.19
7.8
2.8
1.2
1.2
mmol/l
12.58
350
1203
1363
9321
2.02
62.99
7.1
3.8
11.0
10.9
umol/l
0.04
1305
8685
280
964
3.15
62.59
3.8
1.5
9.3
16.1
ug/l
0.22
206
721
1532
10971
2.03
61.54
9.4
6.7
3.9
4.1
e9/l
3.74
1342
9491
177
496
3.76
54.52
2.3
1.6
—
—
—
0
0
462
2229
2.32
52.20
5.6
5.3
1.1
1.0
mmol/l
3.79
430
2057
1493
11378
1.78
41.22
5.2
4.1
6.5
6.6
mmol/l
1.58
1420
10487
2356
21614
2.64
28.24
18.0
12.9
139.8
139.8
mmol/l
0.65
2323
21040
2358
21695
2.60
27.09
18.3
13.0
3.9
4.0
mmol/l
20.84
2314
21077
111
363
3.15
26.77
3.2
2.0
708.9
90.7
u/ml
0.84
92
286
29
28
10.47
26.25
1.2
1.1
—
—
—
0
0
187
822
2.38
25.41
9.5
11.3
—
—
—
0
0
331
1820
1.94
25.27
7.9
7.6
1.2
1.3
mmol/l
0.21
266
1393
331
1844
1.92
24.25
7.9
7.5
12.6
12.0
kpa
1.16
313
1763
331
1844
1.92
24.25
8.0
7.5
5.1
5.1
kpa
0.22
313
1764
1995
17495
1.70
24.22
21.9
13.5
13.5
13.6
%
1.04
1978
17073
1219
9585
1.53
23.52
6.3
5.9
28.0
28.9
%
2.04
1144
8888
2287
20964
2.10
23.28
17.1
11.2
18.7
20.6
mg/l
2.47
1894
16002
276
1500
1.94
21.67
8.6
8.3
123.9
122.6
g/l
0.44
266
1440
313
1797
1.85
20.73
3.2
2.9
—
—
—
0
0
259
1409
1.94
20.23
1.9
2.1
0.2
0.2
g/l
3.74
249
1283
283
1590
1.88
20.04
5.5
3.1
229.4
232.2
u/l
0.17
269
1492
1190
9512
1.48
19.96
6.2
5.7
57.5
56.7
%
1.42
1120
8845
140
611
2.37
19.31
2.0
2.0
5.2
4.6
iu/l
0.26
65
226
309
1902
1.71
15.96
2.6
1.8
383.4
361.5
nmol/l
0.68
289
1732
188
999
1.95
15.68
2.1
1.5
41.1
26.2
u/ml
0.77
182
952
2158
19880
1.64
15.42
16.8
10.0
83.9
82.1
ml/min/173m2
3.96
1901
15968
1787
15822
1.46
15.39
4.5
4.1
11.7
11.2
mm/h
0.66
1662
14695
186
1043
1.85
13.16
6.2
7.3
25.0
24.7
mmol/l
0.53
173
958
347
2328
1.57
12.59
2.9
2.6
21.6
23.6
%
1.69
276
1965
309
2025
1.60
12.38
7.9
6.2
104.2
104.3
mmol/l
0.17
302
1980
133
685
1.99
12.15
4.9
6.0
1.7
1.6
%
0.62
125
639
816
6496
1.38
12.10
3.7
2.7
28.0
33.0
u/l
1.25
773
6161
1522
13356
1.36
11.98
4.6
4.2
587.8
2193.0
e6/l
1.98
19
169
247
1544
1.67
11.95
3.3
3.4
2.1
2.0
mmol/l
0.11
199
1265
370
2561
1.52
11.61
2.8
2.4
2.4
2.4
g/l
0.04
343
2371
67
265
2.57
11.52
1.4
1.4
—
—
—
0
0
244
1550
1.64
11.07
3.4
3.4
5.9
5.8
kpa
0.03
237
1504
146
808
1.86
10.79
11.6
9.6
24.6
24.5
mmol/l
0.30
140
750
398
2847
1.47
10.58
2.8
2.4
12.9
13.8
umol/l
1.69
370
2621
100
489
2.09
10.56
2.2
3.0
—
—
—
0
0
375
2674
1.47
10.10
3.0
2.0
29.9
29.6
s
0.47
365
2574
302
2069
1.52
9.88
2.3
2.2
8.0
6.9
umol/l
0.29
266
1763
522
3970
1.40
9.87
1.5
1.5
—
—
—
0
0
493
3729
1.40
9.60
3.9
3.5
105.9
463.6
ng/l
5.30
362
2684
376
2716
1.45
9.44
2.1
1.7
—
—
—
0
0
275
1871
1.53
9.28
2.0
1.6
—
—
—
0
0
1083
9271
1.30
9.03
3.3
2.8
104.0
100.5
ug/l
0.25
999
8605
2067
19351
1.40
8.88
20.2
12.4
39.7
39.8
%
0.19
1505
14147
272
1872
1.51
8.69
2.0
1.7
—
—
—
0
0
606
4830
1.34
8.35
2.5
2.2
2.9
2.9
mg/l
0.07
518
4113
216
1431
1.56
8.22
9.1
6.6
1.3
1.3
mmol/l
0.52
206
1387
627
5047
1.32
8.02
3.1
2.8
0.4
0.4
e6/l
0.12
474
3712
211
1413
1.54
7.65
3.9
2.3
10.9
10.6
g/l
0.31
193
1297
41
160
2.59
7.36
1.2
1.0
—
—
—
0
0
134
814
1.68
7.28
2.9
2.9
26.2
25.4
mmol/l
1.88
129
784
185
1218
1.56
7.25
1.7
1.6
—
—
—
0
0
15
30
5.02
7.18
1.4
1.5
—
—
—
0
0
740
6170
1.28
7.14
2.6
2.3
54.3
57.4
u/l
1.78
685
5656
235
1644
1.47
6.92
1.2
1.2
161.1
150.0
iu/ml
0.14
88
655
2422
23612
1.90
6.81
27.0
16.9
135.4
135.5
g/l
0.19
2404
23262
367
2788
1.37
6.81
2.9
2.6
4.6
3.7
e6/l
0.45
193
1432
2420
23589
1.88
6.77
26.9
16.8
258.9
258.3
e9/l
0.21
2387
22963
2421
23605
1.89
6.72
26.8
16.8
4.5
4.5
e12/l
5.62
2383
22901
2421
23608
1.88
6.67
26.9
16.8
6.5
6.6
e9/l
1.28
2385
22903
72
372
1.96
6.66
3.6
3.6
57.3
56.8
%
0.12
72
372
481
3829
1.32
6.51
2.5
2.4
5.0
6.7
e6/l
2.49
417
3298
61
300
2.06
6.47
1.3
1.3
—
—
—
0
0
395
3062
1.34
6.42
2.8
2.4
0.8
1.3
e6/l
1.89
217
1700
199
1369
1.49
6.38
9.3
7.5
9.5
9.3
mmol/l
0.10
185
1309
6
0
+∞
6.25
1.3
0.0
—
—
—
0
0
89
504
1.79
6.23
4.7
1.5
41.3
39.4
mg/l
0.15
72
407
58
285
2.06
6.18
4.8
5.6
1383.9
361.2
iu/ml
—
8
40
215
1513
1.46
6.16
3.9
2.9
175.8
163.2
ng/l
0.18
196
1374
88
504
1.77
5.95
4.8
1.5
27.9
42.4
mg/l
0.67
71
406
16
40
4.02
5.89
3.5
2.2
—
—
—
0
0
55
274
2.03
5.68
1.7
1.4
0.3
0.4
nmol/l
1.60
46
229
79
447
1.79
5.58
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
77
435
1.79
5.48
2.8
4.1
0.3
0.4
u/ml
0.53
44
255
236
1728
1.40
5.46
2.6
2.2
31.1
38.1
u/l
1.45
199
1453
194
1375
1.45
5.37
3.3
1.5
67.2
67.4
g/l
0.19
180
1237
26
95
2.76
5.36
1.4
1.8
17.0
13.4
%
0.69
11
45
1510
13915
1.22
5.25
3.2
2.9
42.1
41.4
u/l
0.15
1410
12951
549
4559
1.26
5.25
2.2
1.8
1.2
1.0
mg/l
0.40
422
3421
61
325
1.90
5.23
1.5
1.7
—
—
—
0
0
122
791
1.57
5.18
3.7
3.9
24.1
24.3
mmol/l
0.28
110
706
69
388
1.80
5.01
3.4
3.2
25.1
25.1
mmol/l
0.01
62
337
24
88
2.74
4.94
1.4
1.9
—
—
—
0
0
241
1802
1.37
4.93
2.6
2.2
1.8
1.8
%
0.14
216
1593
19
62
3.08
4.79
6.2
5.1
—
—
—
0
0
59
324
1.84
4.65
2.9
2.7
8.3
8.1
kpa
0.24
53
297
61
340
1.81
4.59
2.3
1.4
—
—
—
0
0
26
104
2.52
4.54
1.7
1.5
16940.1
106453.9
e6/l
0.81
16
61
2320
22562
1.41
4.51
12.5
8.8
24.9
25.1
u/l
0.33
2264
21725
131
896
1.49
4.40
2.0
2.0
36.6
39.2
u/l
0.86
117
798
40
196
2.06
4.39
1.2
1.2
91.7
56.4
u/l
0.93
33
134
124
839
1.50
4.39
2.1
2.2
10.8
13.3
nmol/l
2.68
108
740
154
1089
1.44
4.36
1.4
1.3
31.4
29.2
iu/l
0.38
136
947
39
191
2.06
4.29
4.5
3.1
2.8
0.9
%
1.31
30
144
109
733
1.51
4.00
2.3
2.0
7147.1
3888.2
u/l
0.33
23
310
25
106
2.37
3.90
1.5
1.2
—
—
—
0
0
1128
10289
1.18
3.87
3.7
3.6
0.0
0.0
estimate
1.32
224
1726
57
329
1.75
3.87
2.4
1.5
—
—
—
0
0
48
263
1.84
3.86
1.5
1.4
299.9
328.6
pmol/l
0.37
40
203
32
152
2.12
3.84
1.3
1.1
—
—
—
0
0
52
294
1.79
3.79
1.5
1.4
105.7
111.3
u/ml
0.19
12
53
80
511
1.58
3.71
2.9
2.4
184.0
179.4
%
0.18
73
485
76
480
1.60
3.70
4.1
2.6
3.5
3.6
g/l
0.26
70
452
1115
10187
1.17
3.69
5.0
4.8
0.0
0.0
estimate
0.80
225
1761
27
122
2.23
3.67
1.6
1.5
1610.2
3105.7
e6/l
0.72
21
91
936
8446
1.17
3.59
2.0
1.9
95.6
97.9
pmol/l
0.65
461
4154
54
317
1.72
3.49
2.9
2.4
15.8
16.7
%
0.74
33
155
671
5902
1.19
3.48
1.8
1.6
1.3
1.4
mmol/l
2.61
564
4986
11
31
3.56
3.48
1.6
1.1
—
—
—
0
0
84
552
1.54
3.47
2.7
2.2
93.8
93.0
%
0.14
79
509
56
334
1.69
3.42
1.3
1.5
—
—
—
0
0
206
2631
0.76
3.41
4.6
4.6
32.6
32.8
%
0.06
142
1786
23
101
2.29
3.36
1.8
1.6
—
—
—
0
0
700
6198
1.18
3.34
2.3
2.1
147.1
202.7
u/l
1.58
669
5803
30
148
2.04
3.31
2.0
1.5
—
—
—
0
0
42
235
1.80
3.22
2.6
1.5
—
—
—
0
0
11
33
3.34
3.19
1.2
1.7
—
—
—
0
0
20
86
2.34
3.08
1.5
1.2
—
—
—
0
0
569
4988
1.18
3.03
1.3
1.3
1.8
1.7
u/ml
0.15
147
1356
1099
10133
1.15
3.02
3.7
3.5
0.0
0.0
estimate
0.00
225
1728
20
87
2.31
3.00
1.5
1.2
—
—
—
0
0
81
548
1.49
2.97
2.4
2.1
11.1
11.0
mg/l
0.02
75
506
58
366
1.60
2.90
1.4
1.2
—
—
—
0
0
9
22
4.10
2.88
1.3
1.1
—
—
—
0
0
819
7429
1.15
2.78
3.3
3.4
47.7
57.3
ng/l
0.23
511
4648
323
2711
1.22
2.75
2.5
2.3
105.3
116.2
ug/g
0.40
250
2132
81
559
1.46
2.72
1.4
1.4
329.3
313.6
ug/g
0.34
47
302
486
4243
1.18
2.70
1.4
1.4
—
—
—
0
0
68
454
1.51
2.69
1.6
1.3
14.3
10.7
u/l
1.04
53
372
96
688
1.41
2.65
1.6
1.8
—
—
—
0
0
89
630
1.43
2.63
1.1
1.1
2.0
4.6
u/ml
0.90
13
76
92
656
1.42
2.61
3.0
1.4
10.0
10.4
g/l
0.38
70
550
165
1290
1.30
2.60
3.7
2.7
4.9
4.6
kpa
0.83
157
1251
34
192
1.78
2.58
2.0
1.4
—
—
—
0
0
578
5150
1.16
2.47
2.6
2.2
2218.8
5038.7
umol/l
1.56
508
4448
50
318
1.58
2.47
1.3
1.3
—
—
—
0
0
50
318
1.58
2.47
1.3
1.3
—
—
—
0
0
520
4599
1.17
2.45
1.5
1.5
21.9
21.3
nmol/l
0.15
461
3899
21
103
2.05
2.41
1.3
1.1
70.4
72.3
u/l
0.06
14
74
93
679
1.38
2.34
1.7
1.6
1.5
1.5
g/l
0.17
80
592
92
672
1.38
2.31
1.6
1.7
1.2
1.2
g/l
0.19
85
634
52
340
1.54
2.30
1.4
1.2
309.6
237.3
u/ml
1.00
31
213
96
707
1.37
2.30
3.0
1.4
—
—
—
0
0
90
656
1.39
2.29
1.6
1.8
0.2
0.2
g/l
1.03
83
621
96
708
1.37
2.28
3.0
1.4
3.8
3.8
g/l
0.02
62
503
96
708
1.37
2.28
3.0
1.4
7.2
7.4
g/l
0.30
65
529
31
178
1.75
2.26
3.6
1.7
6.4
797.1
u/ml
0.51
31
166
581
5213
1.15
2.25
3.0
2.9
1128.8
1149.9
ng/l
0.05
492
4369
16
73
2.20
2.21
2.4
1.4
—
—
—
0
0
21
108
1.95
2.15
2.3
1.4
—
—
—
0
0
176
1424
1.25
2.15
1.3
1.3
64.5
48.3
au/ml
—
10
70
6
14
4.29
2.15
1.3
1.0
0.4
0.2
nmol/l
—
6
7
42
266
1.59
2.15
1.9
1.4
—
—
—
0
0
16
74
2.17
2.14
1.0
1.2
121.8
112.0
%
0.70
16
65
20
103
1.95
2.05
1.3
1.1
13.6
15.7
u/l
0.19
12
70
190
1563
1.23
2.02
2.3
2.4
18.2
25.2
au/ml
0.71
16
93
65
460
1.42
1.99
1.2
1.2
—
—
—
0
0
29
171
1.70
1.96
1.4
1.5
—
—
—
0
0
17
84
2.03
1.95
2.4
1.3
—
—
—
0
0
73
531
1.39
1.93
2.7
1.9
2.5
1.7
ug/l
0.38
60
460
89
669
1.34
1.92
3.1
1.4
3.0
3.0
g/l
0.08
65
516
21
113
1.87
1.91
1.5
1.9
—
—
—
0
0
33
205
1.62
1.86
1.9
1.3
—
—
—
0
0
846
7860
1.12
1.83
3.8
3.7
—
—
—
0
0
105
815
1.30
1.83
3.1
2.4
0.6
0.7
%
0.05
100
777
15
73
2.06
1.80
2.5
1.4
—
—
—
0
0
491
4420
1.14
1.80
1.6
1.7
461.9
41181665.2
pmol/l
4.59
390
3708
695
6396
1.12
1.78
3.1
3.1
7.2
7.2
mmol/l
0.04
588
5411
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
54
381
1.43
1.72
2.5
2.1
124.4
131.9
g/l
1.16
44
273
5
13
3.85
1.71
7.8
2.1
—
—
—
0
0
106
833
1.28
1.70
3.1
2.4
1.1
1.2
%
0.93
106
824
22
126
1.75
1.68
2.9
1.3
—
—
—
0
0
22
126
1.75
1.68
2.9
1.3
—
—
—
0
0
22
126
1.75
1.68
2.9
1.3
—
—
—
0
0
21
119
1.77
1.66
1.4
1.4
—
—
—
0
0
17
90
1.89
1.65
1.6
1.8
—
—
—
0
0
21
120
1.76
1.62
1.7
1.5
8.7
7.4
u/l
—
9
52
401
3591
1.14
1.60
1.7
1.7
1132.5
1176.8
nmol/l
0.44
329
2734
23
136
1.70
1.58
2.8
1.5
—
—
—
0
0
184
1552
1.20
1.57
3.0
2.2
65.3
69.5
ml/min/173m2
0.81
79
586
18
99
1.82
1.57
4.2
2.4
584.9
767.5
e6/l
—
9
44
173
1452
1.21
1.56
1.3
1.3
96.3
198.5
u/ml
3.22
159
1338
1442
13844
1.10
1.55
3.3
3.0
—
—
—
0
0
5
15
3.34
1.52
7.8
2.0
22.6
21.7
mg/l
—
5
15
25
154
1.63
1.50
2.7
1.4
—
—
—
0
0
401
3614
1.13
1.46
5.3
3.6
2.1
1.8
ug/l
0.96
361
3236
7
28
2.50
1.45
2.3
3.1
—
—
—
0
0
6
22
2.73
1.43
1.2
1.2
—
—
—
0
0
57
423
1.36
1.41
1.5
1.3
—
—
—
0
0
67
511
1.32
1.38
1.3
1.2
25.7
42.6
u/ml
—
5
60
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
117
958
1.23
1.38
1.6
1.5
—
—
—
0
0
67
868
0.77
1.37
1.4
1.5
—
—
—
0
0
12
61
1.97
1.32
1.2
1.3
—
—
—
0
0
34
233
1.47
1.32
2.1
1.3
—
—
—
0
0
45
326
1.39
1.30
1.4
1.2
5.4
5.9
u/ml
0.09
22
131
6
132
0.45
1.28
1.3
1.3
—
—
—
0
0
45
331
1.37
1.21
1.4
1.2
2.2
3.2
u/ml
0.42
16
102
31
213
1.46
1.20
1.3
1.2
1.8
2.7
ug/l
1.28
26
187
65
506
1.29
1.19
3.8
3.8
3.8
3.8
mmol/l
0.17
59
481
152
1298
1.18
1.19
1.7
1.8
—
—
—
0
0
75
596
1.27
1.18
3.5
1.4
0.7
0.4
g/l
0.26
61
517
14
79
1.78
1.17
1.2
1.3
—
—
—
0
0
74
923
0.80
1.15
1.4
1.5
—
—
—
0
0
40
292
1.38
1.13
1.4
1.3
—
—
—
0
0
121
1019
1.20
1.12
1.5
1.7
—
—
—
0
0
63
494
1.28
1.11
2.9
1.4
0.0
0.0
g/l
0.00
54
452
67
531
1.27
1.09
2.9
1.4
0.0
0.0
g/l
0.34
58
487
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
8
41
1.95
1.08
1.0
1.2
—
—
—
0
0
33
235
1.41
1.08
1.6
1.3
—
—
—
0
0
20
128
1.57
1.08
4.7
2.8
49.1
57.3
%
—
10
86
37
501
0.73
1.08
1.3
1.5
—
—
—
0
0
32
227
1.42
1.08
1.2
1.2
—
—
—
0
0
62
489
1.27
1.06
2.9
1.4
0.0
0.0
g/l
0.00
54
451
7
33
2.12
1.05
1.9
1.4
—
—
—
0
0
72
889
0.80
1.05
2.2
1.7
3.6
3.8
mg/l
0.07
54
618
114
962
1.19
1.05
1.4
1.3
2.8
1.0
u/ml
—
10
81
44
332
1.33
1.03
1.9
2.9
24.7
35.7
umol/l
2.80
38
291
9
46
1.96
1.03
5.7
2.7
—
—
—
0
0
28
196
1.43
1.02
2.1
1.3
—
—
—
0
0
319
2904
1.11
1.02
4.4
3.6
22.6
23.7
%
0.65
166
1268
7
132
0.53
0.98
11.6
17.7
987.7
1500.9
nmol/l
—
7
127
9
49
1.84
0.98
4.8
1.5
—
—
—
0
0
9
49
1.84
0.98
4.8
1.5
—
—
—
0
0
9
49
1.84
0.98
4.8
1.5
—
—
—
0
0
26
366
0.71
0.97
1.7
1.8
—
—
—
0
0
59
469
1.26
0.96
1.5
1.3
52.6
30.2
e6/l
0.39
34
367
9
50
1.80
0.96
1.1
1.3
—
—
—
0
0
59
470
1.26
0.95
1.5
1.4
1199.8
1468.4
e6/l
0.10
40
387
12
70
1.72
0.92
1.1
1.1
—
—
—
0
0
14
86
1.63
0.91
3.6
1.8
22.1
110.0
ug/l
0.47
14
77
14
86
1.63
0.91
4.1
1.6
194.8
190.3
u/l
0.11
14
86
8
42
1.91
0.88
1.1
1.5
51.1
105.9
ng/l
—
8
42
25
177
1.42
0.88
1.1
1.1
—
—
—
0
0
7
129
0.54
0.88
9.1
12.8
569.0
826.7
nmol/l
—
7
124
41
317
1.30
0.85
1.1
1.0
2.1
2.2
u/ml
0.05
25
145
31
230
1.35
0.85
1.7
1.3
—
—
—
0
0
31
230
1.35
0.85
1.7
1.3
—
—
—
0
0
17
112
1.52
0.85
1.0
1.1
—
—
—
0
0
122
1059
1.16
0.84
3.6
3.4
5.2
5.2
kpa
0.10
111
981
113
976
1.17
0.83
1.6
1.6
—
—
—
0
0
44
556
0.79
0.83
1.4
1.4
—
—
—
0
0
226
2047
1.11
0.82
3.0
2.6
0.7
0.7
ug/l
0.30
160
1284
16
105
1.53
0.81
1.3
1.2
—
—
—
0
0
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
68
565
1.21
0.79
3.0
1.4
38.7
38.2
g/l
0.36
57
478
86
732
1.18
0.77
1.7
1.7
328.1
309.4
mu/l
0.20
80
651
60
495
1.22
0.75
1.7
1.6
13936.0
11533.7
e6/l
0.20
48
361
5
24
2.09
0.74
2.2
1.7
—
—
—
0
0
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
13
195
0.66
0.72
1.3
1.1
—
—
—
0
0
71
599
1.19
0.72
1.2
1.3
—
—
—
0
0
565
5365
1.07
0.71
4.2
4.0
0.0
0.0
estimate
1.08
217
1753
661
6311
1.06
0.70
4.0
3.9
8.7
7.9
mg/mmol
0.15
392
3807
183
2016
0.90
0.69
1.9
1.9
—
—
—
0
0
25
187
1.34
0.68
1.3
1.2
0.2
1.0
u/ml
0.70
14
82
71
604
1.18
0.67
1.4
1.3
—
—
—
0
0
114
1007
1.14
0.66
3.6
3.3
2.7
1.7
mmol/l
2.40
90
754
1995
19683
1.07
0.66
5.9
5.6
39.2
39.4
mmol/mol
0.50
1869
18338
11
70
1.57
0.65
1.0
1.0
—
—
—
0
0
2119
21417
0.93
0.65
4.5
4.4
4.7
4.8
mmol/l
1.39
1995
20006
2154
21757
0.93
0.64
5.0
4.9
2.8
2.8
mmol/l
0.07
2011
20207
5
29
1.73
0.64
3.2
2.6
—
—
—
0
0
209
2273
0.91
0.62
1.9
1.9
—
—
—
0
0
71
609
1.17
0.62
1.4
1.3
3.4
6.4
u/ml
—
10
102
2106
21283
0.93
0.62
4.4
4.4
1.5
1.5
mmol/l
4.44
1968
19768
132
1184
1.12
0.61
1.1
1.0
—
—
—
0
0
2030
20533
0.94
0.59
3.9
3.9
1.3
1.3
mmol/l
0.38
1880
18919
479
4554
1.06
0.59
4.3
4.0
1.0
1.0
kg/l
0.10
84
649
8
52
1.54
0.59
1.4
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
19
140
1.36
0.58
1.3
1.2
—
—
—
0
0
35
283
1.24
0.56
1.2
1.1
—
—
—
0
0
38
462
0.82
0.56
1.3
1.4
—
—
—
0
0
83
728
1.14
0.56
1.6
2.0
—
—
—
0
0
38
461
0.82
0.55
1.3
1.4
—
—
—
0
0
38
460
0.82
0.54
1.3
1.4
—
—
—
0
0
38
460
0.82
0.54
1.3
1.4
—
—
—
0
0
19
142
1.34
0.54
1.3
1.2
—
—
—
0
0
28
222
1.26
0.54
1.8
1.4
—
—
—
0
0
21
160
1.32
0.53
1.5
2.2
0.7
2.3
u/field
—
9
72
11
74
1.49
0.53
1.2
1.0
—
—
—
0
0
69
600
1.15
0.53
1.4
1.2
1.4
7.8
u/ml
—
8
58
28
223
1.26
0.52
1.8
1.4
—
—
—
0
0
16
117
1.37
0.52
1.3
1.2
—
—
—
0
0
9
134
0.67
0.51
1.2
1.4
—
—
—
0
0
37
306
1.21
0.50
1.1
1.1
125.7
117.2
%
0.77
32
276
13
179
0.72
0.50
1.2
1.4
1.4
1.5
nmol/l
0.10
13
162
102
916
1.12
0.50
1.3
1.4
—
—
—
0
0
226
2419
0.93
0.49
1.5
1.7
1.4
1.4
%
0.28
195
2136
10
67
1.49
0.49
1.7
1.3
—
—
—
0
0
10
67
1.49
0.49
1.7
1.3
—
—
—
0
0
28
225
1.25
0.49
1.8
1.4
—
—
—
0
0
7
49
1.43
0.46
1.4
2.9
—
—
—
0
0
7
49
1.43
0.46
1.4
2.9
—
—
—
0
0
36
428
0.84
0.45
1.4
1.5
—
—
—
0
0
77
685
1.13
0.45
1.6
1.6
0.5
0.2
iu/ml
0.32
19
135
13
95
1.37
0.43
1.7
1.7
—
—
—
0
0
20
157
1.28
0.43
1.2
1.1
—
—
—
0
0
9
128
0.70
0.43
1.4
1.4
—
647.3
—
0
11
21
166
1.27
0.43
5.0
4.0
—
—
—
0
0
79
708
1.12
0.42
2.5
1.8
—
—
—
0
0
10
70
1.43
0.41
1.4
1.4
—
—
—
0
0
10
70
1.43
0.41
1.4
1.4
—
—
—
0
0
13
96
1.36
0.41
2.2
1.3
—
—
—
0
0
38
323
1.18
0.41
3.3
3.1
0.8
0.8
nmol/l
0.22
31
241
62
548
1.13
0.41
1.4
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
2.4
—
0
8
0
16
0.00
0.41
0.0
1.0
—
0.0
—
0
9
241
2551
0.94
0.41
7.5
6.0
—
—
—
0
0
8
59
1.36
0.41
1.3
1.1
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
0.0
—
0
10
13
97
1.34
0.39
1.3
1.1
—
—
—
0
0
31
260
1.19
0.39
1.2
1.1
—
—
—
0
0
83
750
1.11
0.39
1.9
1.9
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
0.3
—
0
13
70
627
1.12
0.38
1.2
1.1
—
—
—
0
0
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
23
188
1.23
0.37
2.6
1.6
33.0
32.4
pg
0.31
23
188
5
79
0.63
0.35
1.8
2.4
—
—
—
0
0
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
13
167
0.78
0.34
1.3
1.4
9.7
11.8
mmol/l
—
5
41
14
178
0.79
0.34
1.4
1.0
—
—
—
0
0
65
586
1.11
0.33
1.2
1.1
—
—
—
0
0
18
145
1.24
0.33
2.1
1.6
—
—
—
0
0
26
307
0.85
0.33
1.4
1.5
—
—
—
0
0
69
626
1.11
0.32
1.2
1.1
—
—
—
0
0
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
73
665
1.10
0.32
1.4
1.3
240.8
216.6
miu/ml
0.21
35
330
106
1142
0.93
0.32
1.5
1.4
—
—
—
0
0
46
408
1.13
0.31
2.2
2.1
0.9
0.8
nmol/l
0.41
36
336
21
251
0.84
0.31
1.0
1.1
0.2
0.3
u/ml
—
5
65
31
269
1.15
0.29
1.8
1.5
67.6
59.6
%
0.55
18
167
71
653
1.09
0.27
2.0
1.7
—
—
—
0
0
26
224
1.16
0.27
1.7
2.3
38.8
26.0
mg/l
—
9
59
5
71
0.70
0.26
1.0
1.5
6.7
8.8
ug/l
—
5
71
21
244
0.86
0.24
1.3
1.0
—
—
—
0
0
5
38
1.32
0.23
1.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
45
411
1.10
0.21
1.0
1.1
1.3
1.5
u/ml
0.17
24
163
0
12
0.00
0.21
0.0
2.4
—
4.1
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
8
103
0.78
0.21
1.1
1.5
—
—
—
0
0
40
364
1.10
0.20
2.1
1.7
—
—
—
0
0
10
81
1.24
0.18
1.3
1.8
—
—
—
0
0
27
301
0.90
0.18
1.6
1.5
—
—
—
0
0
17
147
1.16
0.18
3.0
2.4
—
—
—
0
0
238
2309
1.03
0.18
19.7
23.1
1.2
1.3
inr
0.53
43
348
51
474
1.08
0.17
1.3
1.2
16.9
3.7
u/ml
—
7
35
15
129
1.16
0.17
1.1
1.1
0.9
1.1
u/l
—
7
66
2099
20912
1.02
0.15
4.8
4.5
5.9
5.9
mmol/l
0.74
1953
19217
22
244
0.90
0.14
1.1
2.0
3.9
4.7
umol/l
0.45
13
171
12
103
1.17
0.13
1.4
1.4
147.1
339.6
pmol/l
—
7
32
13
113
1.15
0.13
1.6
1.5
7.2
8.0
ug/l
0.15
13
92
35
326
1.07
0.12
1.1
1.1
—
—
—
0
0
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
404
3976
1.02
0.12
1.3
1.3
16.3
11.6
u/ml
0.51
150
1591
33
307
1.08
0.12
1.6
1.4
36.0
28.4
u/l
0.45
25
240
410
4164
0.98
0.12
1.3
1.3
40.1
34.2
iu/ml
0.23
132
1316
196
2008
0.97
0.12
1.7
1.7
—
—
—
0
0
11
95
1.16
0.11
1.1
1.1
—
—
—
0
0
18
164
1.10
0.09
1.8
1.1
—
—
—
0
0
17
186
0.91
0.09
1.3
1.1
—
—
—
0
0
17
186
0.91
0.09
1.3
1.1
—
—
—
0
0
17
186
0.91
0.09
1.3
1.1
—
—
—
0
0
35
331
1.06
0.08
1.1
1.1
—
—
—
0
0
17
185
0.92
0.08
1.3
1.1
—
—
—
0
0
21
195
1.08
0.08
1.9
1.4
33.2
34.7
%
0.06
11
119
7
66
1.06
0.08
1.1
1.3
—
—
—
0
0
22
205
1.07
0.08
1.1
1.1
—
—
—
0
0
17
184
0.92
0.07
1.3
1.1
—
—
—
0
0
163
1602
1.02
0.06
2.0
2.3
8.0
7.1
ug/l
0.15
140
1405
8
90
0.89
0.06
2.5
1.7
—
—
—
0
0
8
92
0.87
0.06
1.1
1.1
2044.0
1726.7
miu/ml
—
8
92
10
111
0.90
0.06
1.0
1.2
189.2
346.1
u/l
—
10
99
17
181
0.94
0.05
1.5
1.5
1.0
1.0
g/l
0.01
17
181
13
120
1.08
0.05
1.2
1.1
—
—
—
0
0
45
438
1.03
0.03
2.9
3.6
35.7
23.7
mg/l
0.66
24
276
46
469
0.98
0.02
2.8
2.3
129.0
104.3
ug/min
0.11
27
291
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
103
1.07
0.02
1.3
1.1
—
—
—
0
0
29
298
0.97
0.02
1.1
1.3
7.5
7.5
mmol/l
0.05
21
220
13
123
1.06
0.01
1.1
1.2
—
—
—
0
0
14
145
0.97
0.00
1.1
1.1
—
—
—
0
0
16
156
1.03
0.00
1.8
2.3
553.9
627.5
ml
0.23
11
111
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_THYROID_PAPILLARY_ADENO_EXALLC – Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
GWS hits: 16
This endpoint is excluded (different definition than used in FinnGen).